Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus

Diabetologia
Andrew E HoganDonal O'Shea

Abstract

Glucagon-like peptide 1 (GLP-1) is a gut hormone used in the treatment of type 2 diabetes mellitus. There is emerging evidence that GLP-1 has anti-inflammatory activity in humans, with murine studies suggesting an effect on macrophage polarisation. We hypothesised that GLP-1 analogue therapy in individuals with type 2 diabetes mellitus would affect the inflammatory macrophage molecule soluble CD163 (sCD163) and adipocytokine profile. We studied ten obese type 2 diabetes mellitus patients starting GLP-1 analogue therapy at a hospital-based diabetes service. We investigated levels of sCD163, TNF-α, IL-1β, IL-6, adiponectin and leptin by ELISA, before and after 8 weeks of GLP-1 analogue therapy. GLP-1 analogue therapy reduced levels of the inflammatory macrophage activation molecule sCD163 (220 ng/ml vs 171 ng/ml, p < 0.001). This occurred independent of changes in body weight, fructosamine and HbA1c. GLP-1 analogue therapy was associated with a decrease in levels of the inflammatory cytokines TNF-α (264 vs 149 pg/ml, p < 0.05), IL-1β (2,919 vs 748 pg/ml, p < 0.05) and IL-6 (1,379 vs 461 pg/ml p < 0.05) and an increase in levels of the anti-inflammatory adipokine adiponectin (4,480 vs 6,290 pg/ml, p < 0.002). In individuals with t...Continue Reading

References

May 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·K R FeingoldC Grunfeld
Oct 27, 2004·Journal of the American Society of Nephrology : JASN·Brent E Wisse
May 28, 2011·Trends in Immunology·Elise DalmasMichèle Guerre-Millo
Oct 21, 2011·The Journal of Clinical Endocrinology and Metabolism·Ajay ChaudhuriParesh Dandona
Mar 28, 2012·Diabetologia·T ParknerH J Møller
Sep 7, 2013·Science·Vanessa K RidauraJeffrey I Gordon

❮ Previous
Next ❯

Citations

May 21, 2014·Metabolic Syndrome and Related Disorders·Jongoh Kim, Susan L Samson
Sep 29, 2015·Journal of Atherosclerosis and Thrombosis·Yoshihiro KomoharaMotohiro Takeya
Sep 12, 2015·Current Diabetes Reports·Sine Haugaard Knudsen, Bente Klarlund Pedersen
Jul 30, 2014·Diabetes/metabolism Research and Reviews·Jia LiuYuan Xu
Mar 22, 2015·Diabetes & Metabolism·A J ScheenN Paquot
Jun 28, 2016·Cell Metabolism·Daniel J Drucker
Jun 9, 2016·Expert Opinion on Drug Safety·Lisa M YounkStephen N Davis
Jul 22, 2016·Diabetes Care·Rena M PollackGil Leibowitz
Dec 9, 2016·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P D MitchellP M O'Byrne
Nov 24, 2016·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C GuoX Gu
Feb 28, 2019·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Lusha XiangRobert L Hester
May 6, 2019·Expert Review of Cardiovascular Therapy·Sten Madsbad
Feb 8, 2018·Current Vascular Pharmacology·Mojca LunderMišo Šabovič
Jul 29, 2017·Diabetes/metabolism Research and Reviews·Pamela Di TomoGloria Formoso
Jul 1, 2015·Expert Review of Endocrinology & Metabolism·Karl J NeffCarel W le Roux
Jun 30, 2016·Journal of Leukocyte Biology·Danqing MinSusan V McLennan
Apr 26, 2019·Cancers·Donal O'Shea, Andrew E Hogan
Jun 20, 2019·The Journal of Clinical Endocrinology and Metabolism·Faraaz Ali ShahBryan J McVerry
May 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alina Kuryłowicz, Krzysztof Koźniewski
Jun 11, 2018·Current Diabetes Reports·Dorrin Zarrin Khat, Mansoor Husain
Apr 30, 2019·Frontiers in Endocrinology·Lotte Bjerre Knudsen, Jesper Lau
Sep 4, 2020·Expert Review of Gastroenterology & Hepatology·Mikkel Breinholt KjærHenning Grønbæk
Jan 5, 2017·Clinical Science·Emilie PastelKatarina Kos
Jan 7, 2015·Physiology·Sean ManningRachel L Batterham
May 13, 2017·Scientific Reports·Lan HePaul K S Chan
Mar 13, 2019·International Journal of Molecular Sciences·Hidekatsu Yanai, Hiroshi Yoshida
Nov 22, 2020·Nature Reviews. Nephrology·Radica Z AlicicKatherine R Tuttle
Feb 16, 2021·World Journal of Stem Cells·Kang-Li WangRui Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.